Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Part 1 – Case Presentation Daniel A. Pollyea, MD, MS, presents the case of patient “L.L.” to fellow faculty members Brian A. Jonas, MD, PhD, FACP, and Gabriel…
Part 2 – Case Discussion Daniel A. Pollyea, MD, MS, presents the case of patient “L.L.” to fellow faculty members Brian A. Jonas, MD, PhD, FACP, and Gabriel…
Part 3 – Case Discussion & Wrap-up Daniel A. Pollyea, MD, MS, presents the case of patient “L.L.” to fellow faculty members Brian A. Jonas, MD, PhD, FACP,…
Part 1 – Case Presentation Welcome to the inaugural episode of the AML Clinical Case Series on The Doctor’s Channel! Gabriel N. Mannis, MD, presents the case of…
Part 2 – Case Discussion Gabriel N. Mannis, MD, discusses the case of patient “F.M.” with fellow faculty members Brian A. Jonas, MD, PhD, FACP, and Daniel A.…
Part 3 – Case Discussion & Wrap-up Gabriel N. Mannis, MD, discusses the case of patient “F.M.” with fellow faculty members Brian A. Jonas, MD, PhD, FACP, and…
